Most-read rankings are recalculated at the beginning of the month and are based on full-text and pdf views.
| 1. | Spotswood L. Spruance, Julia E. Reid, Michael Grace, Matthew Samore | ||
| Hazard Ratio in Clinical Trials | |||
|---|---|---|---|
|
Antimicrob. Agents Chemother. Aug 01, 2004; 48: 2787-2792.
(In "Minireviews") |
|||
| 2. | Tuberculosis Drug Screening Program | ||
| Search for New Drugs for Treatment of Tuberculosis | |||
|
Antimicrob. Agents Chemother. Jul 01, 2001; 45: 1943-1946.
(In "Guest Commentary") |
|||
| 3. | Alexander Sulakvelidze, Zemphira Alavidze, J. Glenn Morris | ||
| Bacteriophage Therapy | |||
|
Antimicrob. Agents Chemother. Mar 01, 2001; 45: 649-659.
(In "Minireviews") |
|||
| 4. | Sarah Palmer, Robert W. Shafer, Thomas C. Merigan | ||
| Hydroxyurea Enhances the Activities of Didanosine, 9-[2-(Phosphonylmethoxy)ethyl]adenine, and 9-[2-(Phosphonylmethoxy)propyl]adenine against Drug-Susceptible and Drug-Resistant Human Immunodeficiency Virus Isolates | |||
|
Antimicrob. Agents Chemother. Aug 01, 1999; 43: 2046-2050.
(In "Antiviral Agents") |
|||
| 5. | T. P. Lodise, J. Graves, A. Evans, E. Graffunder, M. Helmecke, B. M. Lomaestro, K. Stellrecht | ||
| Relationship between Vancomycin MIC and Failure among Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia Treated with Vancomycin | |||
|
Antimicrob. Agents Chemother. Sep 01, 2008; 52: 3315-3320.
(In "Clinical Therapeutics") |
|||
| 6. | Cody C. Cain, Dongho Lee, Robert H. Waldo III, Alexis T. Henry, Earl J. Casida, Mansukh C. Wani, Monroe E. Wall, Nicholas H. Oberlies, Joseph O. Falkinham III | ||
| Synergistic Antimicrobial Activity of Metabolites Produced by a Nonobligate Bacterial Predator | |||
|
Antimicrob. Agents Chemother. Jul 01, 2003; 47: 2113-2117.
(In "Susceptibility") |
|||
| 7. | DP Nicolau, CD Freeman, PP Belliveau, CH Nightingale, JW Ross, R Quintiliani | ||
| Experience with a once-daily aminoglycoside program administered to 2,184 adult patients | |||
|
Antimicrob. Agents Chemother. Mar 01, 1995; 39: 650-655.
(In "Articles") |
|||
| 8. | J. M. Rolain, P. Brouqui, J. E. Koehler, C. Maguina, M. J. Dolan, D. Raoult | ||
| Recommendations for Treatment of Human Infections Caused by Bartonella Species | |||
|
Antimicrob. Agents Chemother. Jun 01, 2004; 48: 1921-1933.
(In "Minireviews") |
|||
| 9. | Robert E. W. Hancock, Daniel S. Chapple | ||
| Peptide Antibiotics | |||
|
Antimicrob. Agents Chemother. Jun 01, 1999; 43: 1317-1323.
(In "Minireviews") |
|||
| 10. | Todd P. Levin, Byungse Suh, Peter Axelrod, Allan L. Truant, Thomas Fekete | ||
| Potential Clindamycin Resistance in Clindamycin-Susceptible, Erythromycin-Resistant Staphylococcus aureus: Report of a Clinical Failure | |||
|
Antimicrob. Agents Chemother. Mar 01, 2005; 49: 1222-1224.
(In "Mechanisms Of Resistance") |
|||
| 11. | Federico Perez, Andrea M. Hujer, Kristine M. Hujer, Brooke K. Decker, Philip N. Rather, Robert A. Bonomo | ||
| Global Challenge of Multidrug-Resistant Acinetobacter baumannii | |||
|
Antimicrob. Agents Chemother. Oct 01, 2007; 51: 3471-3484.
(In "Minireviews") |
|||
| 12. | K E Fox | ||
| Total extraction of aminoglycosides from guinea pig and bullfrog tissues with sodium hydroxide or trichloroacetic acid. | |||
|
Antimicrob. Agents Chemother. Apr 01, 1989; 33: 448-451.
(In "Research Article") |
|||
| 13. | Christian G. Giske, Dominique L. Monnet, Otto Cars, Yehuda Carmeli, on behalf of ReAct-Action on Antibiotic Resistance | ||
| Clinical and Economic Impact of Common Multidrug-Resistant Gram-Negative Bacilli | |||
|
Antimicrob. Agents Chemother. Mar 01, 2008; 52: 813-821.
(In "Minireviews") |
|||
| 14. | Marie-Paule Mingeot-Leclercq, Paul M. Tulkens | ||
| Aminoglycosides: Nephrotoxicity | |||
|
Antimicrob. Agents Chemother. May 01, 1999; 43: 1003-1012.
(In "Minireviews") |
|||
| 15. | Stephen H. Gillespie | ||
| Evolution of Drug Resistance in Mycobacterium tuberculosis: Clinical and Molecular Perspective | |||
|
Antimicrob. Agents Chemother. Feb 01, 2002; 46: 267-274.
(In "Minireviews") |
|||
| 16. | Thomas P. Lodise, Ben Lomaestro, Jeffrey Graves, G. L. Drusano | ||
| Larger Vancomycin Doses (at Least Four Grams per Day) Are Associated with an Increased Incidence of Nephrotoxicity | |||
|
Antimicrob. Agents Chemother. Apr 01, 2008; 52: 1330-1336.
(In "Clinical Therapeutics") |
|||
| 17. | Simona Bratu, David Landman, Don Antonio Martin, Claudiu Georgescu, John Quale | ||
| Correlation of Antimicrobial Resistance with β-Lactamases, the OmpA-Like Porin, and Efflux Pumps in Clinical Isolates of Acinetobacter baumannii Endemic to New York City | |||
|
Antimicrob. Agents Chemother. Sep 01, 2008; 52: 2999-3005.
(In "Mechanisms Of Resistance") |
|||
| 18. | Priya M. Rajendran, David Young, Toby Maurer, Henry Chambers, Francoise Perdreau-Remington, Peter Ro, Hobart Harris | ||
| Randomized, Double-Blind, Placebo-Controlled Trial of Cephalexin for Treatment of Uncomplicated Skin Abscesses in a Population at Risk for Community-Acquired Methicillin-Resistant Staphylococcus aureus Infection | |||
|
Antimicrob. Agents Chemother. Nov 01, 2007; 51: 4044-4048.
(In "Clinical Therapeutics") |
|||
| 19. | S. D. Alcaine, S. S. Sukhnanand, L. D. Warnick, W.-L. Su, P. McGann, P. McDonough, M. Wiedmann | ||
| Ceftiofur-Resistant Salmonella Strains Isolated from Dairy Farms Represent Multiple Widely Distributed Subtypes That Evolved by Independent Horizontal Gene Transfer | |||
|
Antimicrob. Agents Chemother. Oct 01, 2005; 49: 4061-4067.
(In "Mechanisms Of Resistance") |
|||
| 20. | David J. Weber, William A. Rutala, Emily E. Sickbert-Bennett | ||
| Outbreaks Associated with Contaminated Antiseptics and Disinfectants | |||
|
Antimicrob. Agents Chemother. Dec 01, 2007; 51: 4217-4224.
(In "Minireviews") |
|||
= from the current issue
Last Updated: 10/03/2008 16:42:16
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |